Cargando…
Monotherapy for partial epilepsy: focus on levetiracetam
Levetiracetam (LEV), the S-enantiomer of alpha-ethyl-2-oxo-1-pyrollidine acetamide, is a recently licensed antiepileptic drug (AED) for adjunctive therapy of partial seizures. Its mechanism of action is uncertain but it exhibits a unique profile of anticonvulsant activity in models of chronic epilep...
Autores principales: | Gambardella, Antonio, Labate, Angelo, Colosimo, Eleonora, Ambrosio, Roberta, Quattrone, Aldo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515905/ https://www.ncbi.nlm.nih.gov/pubmed/18728811 |
Ejemplares similares
-
Levetiracetam in the treatment of epilepsy
por: Abou-Khalil, Bassel
Publicado: (2008) -
Levetiracetam in the treatment of childhood epilepsy
por: Wheless, James W
Publicado: (2007) -
Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures
por: Ulloa, Carol M, et al.
Publicado: (2009) -
Levetiracetam as an alternative therapy for Tourette syndrome
por: Martínez-Granero, MA, et al.
Publicado: (2010) -
Pregabalin for the management of partial epilepsy
por: Ryvlin, Philippe, et al.
Publicado: (2008)